Jakarta (Indonesia Window) – A United Arab Emirates health technology company is committed to providing 10 million doses of COVID-19 vaccine for Indonesia in 2020 in the framework of vaccine development cooperation with Indonesian pharmaceutical producer and distributor Kimia Farma.
Indonesian Foreign Minister Retno Marsudi in a virtual press conference from the UAE’s capital city of Abu Dhabi, on Saturday (Aug 22) said the commitment was one of the results of a meeting she and State-owned Enterprises Minister Erick Thohir held with a local company, Group 42 (G42) Health Care Al Holding Rsc Ltd.
“There will be further discussions between Kimia Farma and G42 in more details regarding this commitment,” the foreign minister said.
She explained that G42 is an artificial intelligence-based health technology company, and has been actively involved in research and development of COVID-19 testing and treatment applications as well as distribution.
Indonesia has sent a team of reviewers to monitor the third phase of clinical test for the vaccine candidate, which is a collaboration product between G42 and a Chinese company, Sinopharm.
In the future, the cooperation among Indonesian companies, G42, and Sinopharm will also be agreed.
“Cooperation in monitoring the third phase of the clinical test for the vaccine candidate from Sinopharm-G42 is very important for the development of vaccine cooperation in the future,” the minister said.
Reporting by Indonesia Window